Antihypertensive treatment v placebo for stroke at a mean of 3.9 years§
| Outcomes | Perindopril + indapamide | Double placebo | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| Stroke | 8.5% | 14% | 43% (30 to 54) | 17 (13 to 27) |
| Major vascular events | 13% | 21% | 40% (29 to 49) | 14 (10 to 20) |
| Outcomes | Perindopril alone | Single placebo | RRR (CI) | NNT |
|---|---|---|---|---|
| §Abbreviations defined in glossary; NNT and CI calculated from data in article. | ||||
| Stroke | 12.3% | 12.9% | 5% (–19 to 23) | Not significant |
| Major vascular events | 17.7% | 18.5% | 4% (–15 to 20) | Not significant |